Home›Companies›Healthcare›Optain

Optain Health, Inc.

Retinal screening cameras and remote eye assessments for clinicians.

Updated Nov 9, 2026·Latest SEC filing Oct 13, 2026·Suggest an edit

About Optain

Optain is a private company based in Charlotte, North Carolina, incorporated in 2022 in Delaware. It has reported $18,468,992 raised in two offerings on Form D since April 2025. Its chief executive is Jeff Dunkel.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 16, 2026Oct 13, 2026$7,468,988of $12.9M target22$339KEquityRule 506(b)Form D ↗
Mar 20, 2025Apr 2, 2025$11,000,004of $28.3M target14$785KEquity, OptionsRule 506(b)Form D ↗
Total, two offerings$18,468,992

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Optain's Form D filed Oct 13, 2026.

Jeff Dunkel
Jeff Dunkel
Chief Executive Officer and director
MH
Mingguang He
Co-Founder & Chief Medical Officer, director
John Beadle
John Beadle
Director
Also a co-founder and managing partner of aegis ventures, director at Ascertain and a director at Hume AI.
MM
Maggie Morse
Director

Earlier filings also listed Thomas Manning (director, last listed May 2023), Michael Woods (director, last listed May 2023) and Jason Sun (director, last listed May 2023).

Sources

  1. SECOptain Health, Inc. filing history
  2. PressOptain Health Series A announcement
  3. InvestorOptain portfolio page